- Home
- AIFA vs MIRA Comparison
AIFA vs MIRA Comparison
Compare AIFA & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIFA | MIRA |
|---|---|---|
| Founded | N/A | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.2M | 31.3M |
| IPO Year | 2017 | 2023 |
Fundamental Metrics
Financial Performance| Metric | AIFA | MIRA |
|---|---|---|
| Price | $4.00 | $0.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 387.2K | 126.5K |
| Earning Date | 11-18-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,655,039.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 20.50 | N/A |
| 52 Week Low | $1.52 | $0.60 |
| 52 Week High | $8.93 | $1.80 |
Technical Indicators
Market Signals| Indicator | AIFA | MIRA |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 34.49 |
| Support Level | $2.80 | $0.61 |
| Resistance Level | $8.93 | $0.82 |
| Average True Range (ATR) | 0.78 | 0.06 |
| MACD | -0.28 | -0.01 |
| Stochastic Oscillator | 4.96 | 2.08 |
Price Performance
Historical ComparisonAbout AIFA All In FutureTech Alliance Inc. Common Stock
All In FutureTech Alliance Inc operates an AI-focused digital infrastructure platform. Its activities include opportunities in AI infrastructure, silicon photonics-enabled computing, fiber-optic network transmission, digital infrastructure services, and technology-related initiatives. The company is also developing the AIFA platform, which is intended to combine AI computing capacity, fiber-optic network infrastructure, AI education, and AI-related applications.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.